Endothelin-1 receptors (ETAR and ETBR) act as a pivotal regulator in the biological effects of ET-1 and represent a potential drug target for the treatment of multiple cardiovascular diseases.The purpose of the study is to discover dual ETA/ETB receptor antagonists from traditional Chinese herbs.Ligand-and structure-based virtual screening was performed to screen an in-house database of traditional Chinese herbs, followed by a series of in vitro bioassay evaluation.Aristolochic acid A (AAA) was first confirmed to be a dual ETA/ETB receptor antagonist based intraceilular calcium influx assay and impedance-based assay.Dose-response curves showed that AAA can block both ETAR and ETBR with IC50 of 7.91 and 7.40 μM,respectively.Target specificity and cytotoxicity bioassay proved that AAA is a selective dual ETA/ETB receptor antagonist and has no significant cytotoxicity on HEK293/ETAR and HEK293/ETBR cells within 24 hours.It is a feasible and effective approach to discover bioactive compounds from traditional Chinese herbs using in silico screening combined with in vitro bioassay evaluation.The structural characteristic of AAA for its activity was especially interpreted, which could provide valuable reference for the further structural modification of AAA.